Data from nearly 6000 smokers with cancer show that it may be easier to predict who will stop smoking than was previously thought.
Lilly makes another radiopharma move in collaboration with Aktis Oncology
Eli Lilly is again dipping into the buzzy area of radiopharmaceuticals by way of private biotech Aktis Oncology. The pharma giant will dish out $60